SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950134-06-006293
Filing Date
2006-03-30
Accepted
2006-03-30 17:28:47
Documents
2
Group Members
JOHN S CLARK IIROBERT W BUTTSSOUTHPOINT CAPITAL ADVISORS LLCSOUTHPOINT GP LLCSOUTHPOINT GP LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d34663sc13g.htm SC 13G 123315
2 JOINT FILING AGREEMENT d34663exv99w1.htm EX-99.1 9052
  Complete submission text file 0000950134-06-006293.txt   134492
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 514-332-32
NYMOX PHARMACEUTICAL CORP (Subject) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50514 | Film No.: 06724409
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 237 PARK AVENUE SUITE 900 NEW YORK NY 10017
Business Address 237 PARK AVENUE SUITE 900 NEW YORK NY 10017 212.692.6350
Southpoint Capital Advisors LP (Filed by) CIK: 0001319998 (see all company filings)

IRS No.: 200975910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G